| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 356.87B | 370.31B | 359.46B | 336.91B | 282.09B |
| Gross Profit | 110.39B | 114.15B | 103.82B | 90.83B | 71.55B |
| EBITDA | 38.85B | 42.60B | 37.89B | 33.45B | 24.27B |
| Net Income | 16.79B | 20.28B | 13.02B | 16.23B | 5.87B |
Balance Sheet | |||||
| Total Assets | 347.61B | 313.34B | 316.82B | 299.36B | 280.81B |
| Cash, Cash Equivalents and Short-Term Investments | 65.72B | 48.60B | 57.87B | 56.19B | 48.71B |
| Total Debt | 68.60B | 61.22B | 65.29B | 77.45B | 80.49B |
| Total Liabilities | 197.90B | 181.93B | 195.59B | 195.62B | 196.84B |
| Stockholders Equity | 143.83B | 125.10B | 114.80B | 98.81B | 79.50B |
Cash Flow | |||||
| Free Cash Flow | 23.93B | 19.32B | 22.19B | 19.24B | 802.00M |
| Operating Cash Flow | 33.76B | 32.03B | 33.88B | 26.61B | 7.06B |
| Investing Cash Flow | -22.30B | -22.12B | -16.77B | -7.33B | -9.80B |
| Financing Cash Flow | 1.76B | -18.79B | -19.35B | -14.03B | -11.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥69.76B | 23.18 | ― | 2.73% | -0.70% | 33.64% | |
69 Neutral | ¥173.91B | 9.04 | 13.53% | 1.34% | -3.63% | -14.77% | |
62 Neutral | ¥86.02B | 9.53 | ― | 1.99% | -0.29% | 119.59% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥7.76T | -69.04 | 4.25% | 1.99% | -7.70% | -39.06% | |
56 Neutral | ¥19.11T | -5.95 | 14.45% | 0.55% | -12.56% | -119.49% | |
54 Neutral | ¥2.71B | -0.65 | ― | 4.68% | -3.51% | -4384.38% |